"We are delighted to have finalized the acquisition and integration of Sentrx Animal Care in such a short space of time. Starting in October, 2024 Sentrx is officially renamed Dômes Pharma Inc."
"We are delighted to have finalized the acquisition and integration of Sentrx Animal Care in such a short space of time. Starting in October, 2024 Sentrx is officially renamed Dômes Pharma Inc."
Use our interactive eye model to delve into specific ocular problems in more detail.
Sign up to take a look at this new tool now.
Exceptional Pet Comfort.
Learn about BioHAnce™ our patented crosslinked Hyaluronic Acid technology. BioHAnce helps to increase compliance and improve outcomes unlike traditional eye drops or support for wound care.
"We are delighted to have finalized the acquisition and integration of Sentrx Animal Care in such a short space of time. Starting in October, 2024 Sentrx is officially renamed Dômes Pharma Inc."
Our revolutionary BioHAnce™ Technology platform sets Sentrx products apart from anything available.
BioHAnce™ is at the forefront of innovation in ophthalmology and epidermal healing that features a patented cross-linked Hyaluronic Acid (HA). HA is a naturally occurring molecule throughout the animal’s body that plays a role in lubrication, hydration and healing. The highest concentrations are found in the eyes and skin. BioHAnce is a patented platform that uses advanced bioengineering technology to create a form of HA with greater activity in less volume that also lasts longer. BioHAnce is uniquely designed to accelerate the natural healing process and extend the duration in ocular and epidermal tissues, which traditional HA connot achieve.
